Methods for reducing tumor cell growth by using antibodies with

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241431, 4241551, 4241741, 4241791, 4241811, 4241831, A61K 39395

Patent

active

058465359

ABSTRACT:
The subject invention relates to methods for reducing tumor cell growth in a mammal by administering compositions which include an antibody having the binding specificity of a monoclonal antibody selected from the group comprising one of those referred to as B1, B3 or B5 conjugated to a toxin, radionuclide or drug.

REFERENCES:
Kreitman, R.J. , et al., Abstract, "Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin, " Bioconjug Chem, 3(1) :63-8 (1992 Jan-Feb).
Benhar, I., et al. , "Characterization of B1 (Fv) PE38 and B1 (dsFv) pE38: Single-Chain and Disulfide-stabilized Fv Immunotoxins with Increased Activity That Cause Complete Remissions of Established Human Carcinoma Xenografts in Nude Mice, " Clinical Cancer Resarch,vol. 1, pp. 1023-1029 (Sept. 1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for reducing tumor cell growth by using antibodies with does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for reducing tumor cell growth by using antibodies with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing tumor cell growth by using antibodies with will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-174568

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.